BlackRock
NDRA icon

BlackRock’s ENDRA Life Sciences NDRA Stock Holding History

BlackRock’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$218 – 5352
2023
Q4 		– Hold
0
– – – 5316
2023
Q3 		– Hold
0
– – – 5393
2023
Q2 		– Hold
0
– – – 5458
2023
Q1 		– Hold
0
– – – 5511
2022
Q4 		– Hold
0
– – – 5675
2022
Q3 		– Hold
0
– – – 5751
2022
Q2 		– Sell
-3
Closed -$26.8K – 5935
2022
Q1 		$40K Hold
3
– – ﹤0.01% 5459
2021
Q4 		$75K Hold
3
– – ﹤0.01% 5341
2021
Q3 		$180K Hold
3
– – ﹤0.01% 5006
2021
Q2 		$231K Buy
+3
New +$236K ﹤0.01% 4875

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

BlackRock's NDRA Position: Q1 2024 in Review

BlackRock held its ENDRA Life Sciences (NDRA) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5352.

BlackRock first reported a position in NDRA in Q2 2021 and has held it in 4 quarters since. The position peaked at $231K in Q2 2021. 8 funds tracked by Wall St. Rank hold NDRA as of Q1 2024.

  • BlackRock held 0 shares of ENDRA Life Sciences worth $0 as of Q1 2024.
  • BlackRock left its ENDRA Life Sciences share count unchanged in Q1 2024.
  • ENDRA Life Sciences made up ﹤0.01% of BlackRock's portfolio in Q1 2024, its #5352 holding.
  • BlackRock first reported a position in ENDRA Life Sciences in Q2 2021 and has held it in 4 quarters since.
  • BlackRock's ENDRA Life Sciences position peaked at $231K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.